Contract facts
FederalNo full NAICS 325413 intel page yet. Browse NAICS intelligence
Blood Coagucheks Po Change is a federal award for 261-Network Contract Office 21 (36C261) held by Roche Diagnostics Corp. Estimated value $149K ($50K obligated). Current period of performance ends Sep 30, 2025 (potential Sep 30, 2028). Last award drew 1 bidder. Place of performance: SAN FRANCISCO CA.
Blood coagucheks po change. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Sep 30, 2025 (386 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on 36C26124F0010? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordRoche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C26124F0010?
36C26124F0010 (Blood coagucheks po change) is a 261-Network Contract Office 21 (36C261) award with a potential value of $149K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C261-24-F-0010?
36C261-24-F-0010 is the dashed form of PIID 36C26124F0010 (Blood coagucheks po change), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C26124F0010?
261-Network Contract Office 21 (36C261) awarded 36C26124F0010 to Roche Diagnostics Corp (potential $149K).
Who is the incumbent on 36C26124F0010?
Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2025.
When does Roche Diagnostics Corp’s 36C26124F0010 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C26124F0010? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.